Sandbox:Hannan1

Revision as of 15:07, 22 January 2019 by Hannan Javed (talk | contribs)
Jump to navigation Jump to search
Neuroendocrine tumor Clinical manifestations Dianosis Gold

standard

Other features
Symptoms Signs Blood Gross Histology Immunohistochemistry Imaging Others
Medullary thyroid carcinoma[1]
  • Dysphagia
  • Hoarseness
  • Respiratory difficulty
  • Flushing
  • Diarrhea
  • Weight loss
  • Palpable neck

mass

  • Signs of Cushing

syndrome

↑ Calcitonin

↑ Serum

calcium

↑ or - Cortisol

↑ CEA level

White or gray in color

Firm to palpation

Nests of uniform cells

Deposition of stromal amyloid

Granular chromatin

C-cell hyperplasia

Calcitonin

Chromogranin A

Carcinoembryonic antigen (CEA)

Solid thyroid nodule (US)

CT scan/MRI and PET scan for metastatis

Genetic testing FNA cytology with immunohisto-

chemistry and

calcitonin levels

Associated with MEN 2A and 2B

Familial association with RET mutations

May present as Cushing syndrome

Pheochromocytoma
Merkel cell carcinoma
Parathyroid adenoma
Paraganglioma
Pituitary gland tumors
Neuroendocrine tumors of the ovaries or testicles
Thymic neuroendocrine cancer
Lung neuroendocrine tumors Typical carcinoid tumours
Atypical carcinoid tumours
Large cell lung neuroendocrine carcinomas
Small cell lung neuroendocrine carcinomas
Pancreatic neuroendocrine tumours Gastrinoma
Insulinoma
Glucagonoma
Somatostatinoma
VIPoma
ACTHoma
Gastric neuroendocrine tumors Type I GNET
Type II GNET
Type III GNET
Type IV GNET
Duodenal neuroendocrine tumors Gastrinomas
Somatostatinomas
Gangliocytic paraganglionomas
Nonfunctioning NET
neuroendocrine carcinomas
Jejuno-Ileal neuroendocrine tumors
Appendix neuroendocrine tumors
Colon neuroendocrine tumors
Rectum neuroendocrine tumors
  1. Roy M, Chen H, Sippel RS (2013). "Current understanding and management of medullary thyroid cancer". Oncologist. 18 (10): 1093–100. doi:10.1634/theoncologist.2013-0053. PMC 3805151. PMID 24037980.